Dimerix

Dimerix Short-term Debt

The Short-Term Debt of Dimerix (DXB.AX) as of Oct 11, 2026 is 124,088.00 AUD. In the previous year, Short-Term Debt was 97,481.00 AUD — a change of 27.29% (higher).

Short-term Debt

124,088.00AUD

YoY

27.29%

Last updated:

Short-Term Debt of Dimerix is 2026 124,088.00 AUD. Short-Term Debt of Dimerix was 2025 97,481.00 AUD. It decreases by 27.29% higher compared to the previous year.

The Dimerix Short-term Debt history

  • 3 Years

  • 10 Years

  • 25 Years

  • Max

Short-term Debt
Date
Short-term Debt
Jan 1, 2019
1.09 M AUD
Jan 1, 2020
1.09 M AUD
Jan 1, 2021
5.09 M AUD
Jan 1, 2022
104,234.00 AUD
Jan 1, 2023
5.96 M AUD
Jan 1, 2024
80,167.00 AUD
Jan 1, 2025
97,481.00 AUD
Jan 1, 2026
124,088.00 AUD
The Dimerix Short-term Debt history
YEARShort-term DebtYoY
124,088.00AUD+27.29%
97,481.00AUD+21.60%
80,167.00AUD-98.65%
5.96 MAUD+5,615.80%
104,234.00AUD-97.95%
5.09 MAUD+365.41%
1.09 MAUD0.00%
1.09 MAUD—
0.00AUD—
0.00AUD—
Access this data via the Eulerpool API

Dimerix Stock analysis

What does Dimerix do? Dimerix Ltd is an Australian biotechnology company specializing in the development of innovative therapies for various medical needs. Their business model is based on identifying new targets for drug development, often through collaborations with other biotech or pharmaceutical companies. Dimerix focuses on cancer therapy, utilizing their innovative platform technology to identify and test a variety of drug candidates. They also have a pipeline of medications for kidney and lung diseases, as well as inflammation and pain. Dimerix actively seeks partnerships with other companies and research institutions to bring innovative therapies to market. One of their key products, DMX-200, is currently in phase II clinical trials for the treatment of kidney diseases and has shown promising results. Overall, Dimerix is well-positioned to continue bringing successful therapies to market in the future. Dimerix is one of the most popular companies on Eulerpool.

Frequently Asked Questions about Dimerix stock

Short-Term Debt of Dimerix is 124,088.00 AUD in 2026.

Short-Term Debt of Dimerix changed from 97,481.00 AUD to 124,088.00 AUD, representing a 27.29% change. The value is higher than the previous year.

On Eulerpool you can find the complete historical development of Short-Term Debt Dimerix since 2006 – with annual values, charts, and detailed analysis.

Short-term debt represents borrowings due within one year. High short-term debt relative to cash can signal liquidity risk.

Short-Term Debt's AUD is a key factor for investors. Changes in this metric can signal improving or deteriorating fundamentals, directly impacting the stock price. On Eulerpool, you can track Short-Term Debt's Dimerix historically and in real time.

Access this data via the Eulerpool API

Balance Sheet — Dimerix

All Key Metrics — Dimerix